SCANDIDOS AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.73 SEK | +2.37% |
|
+8.12% | -14.78% |
| Mar. 13 | ScandiDos AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 | CI |
| 2023 | Sweden's ScandiDos Gets Radiation Therapy Device Orders from China; Shares Up | MT |
| Sales 2022 | 61.52M 5.68M | Sales 2023 | 65.45M 6.04M | Capitalization | 98.52M 9.1M |
|---|---|---|---|---|---|
| Net income 2022 | -7M -646K | Net income 2023 | -9M -831K | EV / Sales 2022 | 1.39 x |
| Net cash position 2022 | 6.24M 576K | Net cash position 2023 | 3.55M 327K | EV / Sales 2023 | 1.45 x |
| P/E ratio 2022 |
-12.3
x | P/E ratio 2023 |
-10.8
x | Employees | 30 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 48.42% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.37% | ||
| 1 week | +8.12% | ||
| Current month | -3.62% | ||
| 1 month | +12.70% | ||
| 3 months | -19.16% | ||
| 6 months | -3.62% | ||
| Current year | -14.78% |
1 week
1.62
1.85
1 month
1.541.85
Current year
1.482.75
1 year
1.482.75
3 years
1.484.55
5 years
1.485.38
10 years
1.4815.10
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 64 | 01-02-28 | |
| Chief Executive Officer | 46 | 20-08-31 | |
Henriette Münch
DFI | Director of Finance/CFO | 44 | 21-11-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tom Åke Sundelin
BRD | Director/Board Member | 59 | 18-09-30 |
| Founder | 64 | 01-02-28 | |
| Chairman | 54 | 23-09-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 1.73 | +2.37% | 50,703 |
| 24-04-19 | 1.69 | -3.43% | 112,914 |
| 24-04-18 | 1.75 | 0.00% | 168,654 |
| 24-04-17 | 1.75 | +4.79% | 339,867 |
| 24-04-16 | 1.67 | +4.37% | 669,196 |
Delayed Quote Nasdaq Stockholm, April 22, 2024 at 11:06 am EDT
More quotes
ScandiDos AB is a Sweden-based company active within the medical equipment sector. The Company's competence includes the design and development of radiation detectors, electrometers and application software, as well as clinical experience in medical physics and radiation measurements. The Company's business focuses on developing such applications as Arc Therapy - IMAT/VMAT, Tomotherapy, IMRT and Machine QA, among others. ScandiDos AB markets its products under the Delta4 brand. Delta4 offers Delta4AT - At Treatment in-vivo dosimetry for advanced RT and Delta4PT - Pre Treatment volumetric plan QA, among others. It operates in Europe, Asia, North America and Asia, and through numerous distributors and subsidiaries, including Additec GmbH and Conmedica GmbH in Germany, and ScandiDos SAS in France.
Calendar
2024-06-17
- Q4 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -14.78% | 7.23M | |
| -45.63% | 2.61B | |
| +11.47% | 1.76B | |
| -2.14% | 1.51B | |
| +22.21% | 1.17B | |
| -13.27% | 943M | |
| -22.88% | 883M | |
| -5.96% | 701M | |
| -16.10% | 693M | |
| +12.97% | 509M |
- Stock Market
- Equities
- SDOS Stock
